These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30873608)

  • 1. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical relevance of intragenic
    Cosemans N; Vandenhove L; Vogels A; Devriendt K; Van Esch H; Van Buggenhout G; Olivié H; de Ravel T; Ortibus E; Legius E; Aerssens P; Breckpot J; R Vermeesch J; Shen S; Fitzgerald J; Gallagher L; Peeters H
    J Med Genet; 2020 May; 57(5):347-355. PubMed ID: 31932357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.
    Al Shehhi M; Forman EB; Fitzgerald JE; McInerney V; Krawczyk J; Shen S; Betts DR; Ardle LM; Gorman KM; King MD; Green A; Gallagher L; Lynch SA
    Eur J Med Genet; 2019 Mar; 62(3):204-209. PubMed ID: 30031152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further insight into the neurobehavioral pattern of children carrying the 2p16.3 heterozygous deletion involving NRXN1: Report of five new cases.
    Alfieri P; Scibelli F; Sinibaldi L; Valeri G; Caciolo C; Novello RL; Novelli A; Digilio MC; Tartaglia M; Vicari S
    Genes Brain Behav; 2020 Sep; 19(7):e12687. PubMed ID: 32658356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.
    Lowther C; Speevak M; Armour CM; Goh ES; Graham GE; Li C; Zeesman S; Nowaczyk MJ; Schultz LA; Morra A; Nicolson R; Bikangaga P; Samdup D; Zaazou M; Boyd K; Jung JH; Siu V; Rajguru M; Goobie S; Tarnopolsky MA; Prasad C; Dick PT; Hussain AS; Walinga M; Reijenga RG; Gazzellone M; Lionel AC; Marshall CR; Scherer SW; Stavropoulos DJ; McCready E; Bassett AS
    Genet Med; 2017 Jan; 19(1):53-61. PubMed ID: 27195815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of NRXN1 deletions: clinical and molecular characterization.
    Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
    Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.
    Schaaf CP; Boone PM; Sampath S; Williams C; Bader PI; Mueller JM; Shchelochkov OA; Brown CW; Crawford HP; Phalen JA; Tartaglia NR; Evans P; Campbell WM; Tsai AC; Parsley L; Grayson SW; Scheuerle A; Luzzi CD; Thomas SK; Eng PA; Kang SH; Patel A; Stankiewicz P; Cheung SW
    Eur J Hum Genet; 2012 Dec; 20(12):1240-7. PubMed ID: 22617343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
    Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
    BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurexins and neuropsychiatric disorders.
    Kasem E; Kurihara T; Tabuchi K
    Neurosci Res; 2018 Feb; 127():53-60. PubMed ID: 29221905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder.
    Cameli C; Viggiano M; Rochat MJ; Maresca A; Caporali L; Fiorini C; Palombo F; Magini P; Duardo RC; Ceroni F; Scaduto MC; Posar A; Seri M; Carelli V; Visconti P; Bacchelli E; Maestrini E
    J Cell Mol Med; 2021 Mar; 25(5):2459-2470. PubMed ID: 33476483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila.
    Zweier C; de Jong EK; Zweier M; Orrico A; Ousager LB; Collins AL; Bijlsma EK; Oortveld MA; Ekici AB; Reis A; Schenck A; Rauch A
    Am J Hum Genet; 2009 Nov; 85(5):655-66. PubMed ID: 19896112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature.
    Béna F; Bruno DL; Eriksson M; van Ravenswaaij-Arts C; Stark Z; Dijkhuizen T; Gerkes E; Gimelli S; Ganesamoorthy D; Thuresson AC; Labalme A; Till M; Bilan F; Pasquier L; Kitzis A; Dubourgm C; Rossi M; Bottani A; Gagnebin M; Sanlaville D; Gilbert-Dussardier B; Guipponi M; van Haeringen A; Kriek M; Ruivenkamp C; Antonarakis SE; Anderlid BM; Slater HR; Schoumans J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):388-403. PubMed ID: 23533028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of speech and language phenotype in children with NRXN1 deletions.
    Brignell A; St John M; Boys A; Bruce A; Dinale C; Pigdon L; Hildebrand MS; Amor DJ; Morgan AT
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):700-708. PubMed ID: 30358070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare heterozygous genetic variants of NRXN and NLGN gene families involved in synaptic function and their association with neurodevelopmental disorders.
    Gerik-Celebi HB; Bolat H; Unsel-Bolat G
    Dev Neurobiol; 2024 Jul; 84(3):158-168. PubMed ID: 38739110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders.
    Hu Z; Xiao X; Zhang Z; Li M
    Mol Psychiatry; 2019 Oct; 24(10):1400-1414. PubMed ID: 31138894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays].
    Wang L; Shi P; Ren H; Xue S; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1200-1204. PubMed ID: 36317203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids.
    Sebastian R; Jin K; Pavon N; Bansal R; Potter A; Song Y; Babu J; Gabriel R; Sun Y; Aronow B; Pak C
    Nat Commun; 2023 Jun; 14(1):3770. PubMed ID: 37355690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived
    Pak C; Danko T; Mirabella VR; Wang J; Liu Y; Vangipuram M; Grieder S; Zhang X; Ward T; Huang YA; Jin K; Dexheimer P; Bardes E; Mitelpunkt A; Ma J; McLachlan M; Moore JC; Qu P; Purmann C; Dage JL; Swanson BJ; Urban AE; Aronow BJ; Pang ZP; Levinson DF; Wernig M; Südhof TC
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.